Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Skin cancer
Closed
Phase 3
This trial is looking at 2 new drugs called dabrafenib and trametinib for advanced melanoma. It is for people whose melanoma cells have a change in a gene called BRAF.
Recruitment start: 1 May 2012
Recruitment end: 30 November 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Nathan
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 3 December 2012
CRUK internal database number: 9580
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
